@CNN: A pharmaceutical exec defended his company’s recent 400% drug price increase, telling the Financial Times his company had a “moral requirement to sell the product at the highest price.”
The head of the FDA blasted the executive in a response on Twitter. https://t.co/7LxsZOQxsr https://t.co/io3taux5nd
A pharmaceutical exec defended his company's recent 400% drug price increase, telling the Financial Times his company had a "moral requirement to sell the product at the highest price."
The head of the FDA blasted the executive in a response on Twitter. https://t.co/7LxsZOQxsr pic.twitter.com/io3taux5nd
— CNN (@CNN) September 11, 2018